Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Botulinum Toxin in the Treatment of Androgenic Alopecia

NCT05456087 is registered in ClinicalTrials.gov with Zel Skin and Laser Specialists as lead sponsor.

NCT NCT05456087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05456087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Botulinum Toxin in the Treatment of Androgenic Alopecia
Lead sponsor
Zel Skin and Laser Specialists
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 12, 2022
Completion date
December 31, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia